Arylalkylamine vanadium (V) salts for the treatment and/or prevention of diabetes mellitus

Details for Australian Patent Application No. 2005259231 (hide)

Owner Genmedica Therapeutics SL Universidad De Barcelona

Inventors Font, Francesc Yraola; Prieto, Manuel Palacin; Exposito, Miriam Royo; Ymbert, Xavier Testar; Marti, Anna Abella; Palomera, Fernando Albericio; Clauzel, Luc Marti; Mian, Alec; Vicente, Silvia Garcia; Olarte, Antonio Zorzano

Agent Spruson & Ferguson

Pub. Number AU-A-2005259231

PCT Pub. Number WO2006/003189

Priority P200401730 02.07.04 ES

Filing date 1 July 2005

Wipo publication date 12 January 2006

International Classifications

C07C 211/65 (2006.01) Compounds containing amino groups bound to a carbon skeleton

A61K 31/14 (2006.01) - Quaternary ammonium compounds, e.g. edrophonium, choline

A61K 31/28 (2006.01) - Compounds containing heavy metals

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/003189 Priority application(s): WO2006/003189

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259235-Functional screening assay

2005259229-Dishwasher with comminution device